We are live on
!
Find out more
CC
Cannell Capital Portfolio holdings
AUM
$163M
1-Year Est. Return
40.62%
This Fund
S&P 500
This Quarter
Est. Return
+11.13%
1 Year Est. Return
+40.62%
3 Year Est. Return
+130.22%
5 Year Est. Return
+162.5%
10 Year Est. Return
+2,439.17%
AUM
$350M
AUM Growth
+$34.9M
(+11%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
52.18%
Holding
84
New
17
Increased
25
Reduced
14
Closed
8
Top Buys
| 1 |
eHealth
EHTH
|
+$14.6M |
| 2 |
HBP
Huttig Building Products, Inc.
HBP
|
+$7.04M |
| 3 |
TAX
Liberty Tax, Inc. Class A
TAX
|
+$5.78M |
| 4 |
TAST
Carrols Restaurant Group, Inc.
TAST
|
+$3.35M |
| 5 |
HCCI
Heritage-Crystal Clean, Inc.
HCCI
|
+$3.25M |
Top Sells
| 1 |
HAPN
Happen Inc
HAPN
|
+$8.51M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$6.83M |
| 3 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$6.24M |
| 4 |
NAME
Rightside Group, Ltd.
NAME
|
+$3.16M |
| 5 |
EXTN
Exterran Corporation
EXTN
|
+$2.97M |
Sector Composition
| 1 | Healthcare | 18.7% |
| 2 | Financials | 18.35% |
| 3 | Industrials | 15.83% |
| 4 | Energy | 13.7% |
| 5 | Consumer Discretionary | 8.26% |
Similar funds
IVGAI
SIM
BBFA
PCR
PBO
DJFS
DC
KCM
Cannell Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Cannell Capital held 84 positions worth $350M, up 11% from $315M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Cannell Capital deployed $12.1M of net new capital in Q2 2017, opening 17 new positions and adding to 25 existing holdings. Its largest new stake was Kindred Biosciences, Inc.: 379,874 shares worth $3.27M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was BioTelemetry, Inc., an estimated $6.83M trimmed.
- Cannell Capital's largest Q2 2017 buy was Kindred Biosciences, Inc.: 379,874 shares worth $3.27M.
- Cannell Capital added most to eHealth in Q2 2017, an estimated $14.6M increase.
- Cannell Capital's biggest Q2 2017 reduction was BioTelemetry, Inc., cutting an estimated $6.83M.
- Cannell Capital fully exited Happen Inc in Q2 2017, selling an estimated $8.51M.
- Cannell Capital's ten largest holdings make up 52% of its $350M portfolio in Q2 2017.
- Cannell Capital opened 17 new positions and closed 8 in Q2 2017.
- Cannell Capital's portfolio value rose 11% quarter-over-quarter to $350M.
Based on Cannell Capital's 13F filing for Q2 2017, filed 14 Aug 2017.